On the nature of genetic changes required for the development of esophageal cancer

Molecular Carcinogenesis

Volumn 36, Issue 2, 2003, Pages 82-89

  Uys, Pieter ^a   Van Helden, Paul D ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Cancer; Dysplasia; Esophageal; Genes; Mutations; p53

Indexed keywords

PROTEIN P53;

ADOLESCENT; ADULT; AGED; ARTICLE; CARCINOGENESIS; CHILD; CHROMOSOME ABERRATION; DISEASE COURSE; DNA MICROARRAY; DYSPLASIA; ENVIRONMENTAL FACTOR; ESOPHAGUS CANCER; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGE FACTORS; CELL TRANSFORMATION, NEOPLASTIC; ESOPHAGEAL NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MALE; MODELS, BIOLOGICAL; MUTATION; NORWAY; ONTARIO; RISK FACTORS; SEX CHARACTERISTICS; SOUTH AFRICA;

EID: 0037311765     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/mc.10100     Document Type: Article

References (30)

1. Hahn WC, Weinberg RA. Modelling the molecular circuitry of cancer. Nature Rev 2002;2:331-341.
2. Risch A, Wallace DM, Bathers S, Sim E. Slow N-acetylation is a susceptibility factor in occupational and smoking related bladder cancer. Hum Mol Genet 1995;4:231-236.
3. Garber ME, Troyanskaya OG, Schluens K, et al. Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci USA 2001;98:13784-13789.
4. Bhattacharjee A, Richards WG, Staunton J, et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA 2001;98:13790-13795.
5. Du Plessis L, Dietzch E, van Gele M, et al. Mapping of novel regions of DNA gain and loss by comparative genomic hybridization in esophageal carcinoma in the black and coloured populations of South Africa. Cancer Res 1999;59:1877-1883.
6. Armitage P, Doll R. The age distribution of cancer and a multi-stage theory of carcinogenesis. Br J Cancer 1954;8:1-12.
7. Renan MJ. How many mutations are required for tumorigenesis? Implications from human cancer data. Mol Carcinog 1993;7:139-146.
8. Renan MJ. Is there a lung-cancer susceptibility gene? Int J Cancer 1997;74:359-361.
9. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87:159-170.
10. 2 gene mutations in esophageal tumors from a high-incidence area in South Africa. Int J Cancer 1998;78:544-549.
11. Sitas F. Cancer in South Africa. National Cancer Registry of South Africa. Annual Statistical Reports for 1988 and 1993-1995, Johannesburg: South African Institute for Medical Research, 1992.
12. www.kreftregisteret.no
13. www.cancercare.on.ca
14. Hall BG. Adaptive mutations in Esherichia coli as a model for the multiple mutational origins of tumors. Proc Natl Acad Sci USA 1995;92:5669-5673.
15. Hall BG. Adaptive mutagenesis: A process that generates almost exclusively beneficial mutations. Genetica 1998;102-103:109-125.
16. Hu N, Huang J, Emmert-Buck MR, et al. Frequent inactivation of the TP53 gene in esophageal squamous cell carcinoma from a high-risk population in China. Clin Cancer Res 2001;7(4):883-891.
17. Mori M, Mimori K, Shiraishi T, et al. Altered expression of Fhit in carcinoma and precarcinomatous lesions of the esophagus. Cancer Res 2000;60(5):1177-1182.
18. Ralhan R, Mathew R, Arora S, Bahl R, Shukla NK, Mathur M. Frequent alternations in the expression of tumor suppressor genes p161NK4A and pRb in esophageal squamous cell carcinoma in the Indian population. Cancer Res Clin Oncol 2000;126(110):655-660.
19. Jin Y, Zhang W, Liu B. Abnormal expression of p53, Ki67 and iNOS in human esophageal carcinoma in situ in pre-malignant lesions. Zhonghua Zhong Liu Za Zhi 2001;23(2):129-131.
20. Ikeguchi M, Sakatani T, Ueta T, et al. Correlation between cathepsin D expression and p53 protein nuclear accumulation in esophageal squamous cell carcinoma. J Clin Pathol 2002;55(2):121-126.
21. Fagundes RB, Mello CR, Tollens P, et al. p53 protein in esophageal mucosa of individuals at high risk of squamous cell carcinoma of the esophagus. Dis Esophagus 2001;14(3-4):185-190.
22. Ohbu M, Kobayashi N, Okayasu I. Expression of cell cycle regulatory proteins in the multistep process of esophageal carcinogenesis: Stepwise over-expression of cyclin E and p53, reduction of p21(WAF1/CIP1) and dysregulation of cyclin D1 and p37(KIP1). Histopathology 2001;39(6):589-596.
23. Saeki H, Ohno S, Miyazaki M, et al. p53 protein accumulation in multiple esophageal squamous cell carcinoma: Relationship to risk factors. Oncology 2002;62(2):175-179.
24. Tanaka H, Shimada Y, Harada H, et al. Methylation of the 5′ CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas. Cancer Res 1998;58(15):3429-3434.
25. Bahl R, Arora S, Nath N, Mathur M, Shukla NK, Ralhan R. Novel polymorphism in p21(waf1/cip1) cyclin dependent kinase inhibitor gene: Association with human esophageal cancer. Oncogene 2000;19(3):323-328.
26. Sarbia M, Tekin U, Zeriouh M, Donner A, Gabbert HE. Expression of the RB protein, allelic imbalance of the RB gene and amplification of the CDK4 gene in metaplasias, dysplasias and carcinomas in Barrett's oesophagus. Anticancer Res 2001;21(1A):387-392.
27. Mathew R, Arora S, Mathur M, Chattopadhyay TK, Ralhan R. Esophageal squamous cell carcinomas with DNA replication errors (RER+) are associated with p16/pRb loss and wild-type p53. J Cancer Res Clin Oncol 2001;127(10):603-612.
28. Matsha T, Erasmus R, Kafuko AB, Mugwanya D, Stepien A, Parker MI. Human papillomavirus associated with esophageal cancer. J Clin Pathol 2002;55:587-590.
29. Van Helden PD, Beyers AD, Bester AJ, Jaskiewicz K. Esophageal cancer: Vitamin and lipotrope deficiencies in an at-risk South African population. Nutr Cancer 1987;10:247-255.
30. Jaskiewicz J, Marasas WFO, Lazarus C, Beyers AD, van Helden PD. Association of esophageal cytological abnormalities with vitamin and lipotrope deficiencies in populations at risk for esophageal cancer. Anticancer Res 1988;8:711-716.